Prof. Chezy Barenholz teaches in the Dpartment of Biochemistry and Molecular Biology, The Hebrew University. He is the developer of DOXIL, which received approval for use in the USA in 1996 and in Europe in 1997. It is extensively used to treat ovarian and breast cancer.
Back to Fighting COVID-19 / Coronavirus Webinars